To include your compound in the COVID-19 Resource Center, submit it here.

Braeburn raises $110M mezzanine round

Braeburn Pharmaceuticals Inc. (Princeton, N.J.) closed on Jan. 10 a $110 million mezzanine financing led by new investor

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE